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Prevention of Nosocomial Transmission of Norovirus by
Strategic Infection Control Measures
Vincent C. C. Cheng, MD;1,2 Lisa M. W. Wong, MSc;2 Josepha W. M. Tai, MHSc;2 Jasper F. W. Chan, MD;1
Kelvin K. W. To, MD;1 Iris W. S. Li, MD;1 Ivan F. N. Hung, MD;3 K. H. Chan, PhD;1
P. L. Ho, MD;1 K. Y. Yuen, MD1
background. Nosocomial outbreaks of norovirus infection pose a great challenge to the infection control team.
methods. Between November 1, 2009, and February 28, 2010, strategic infection control measures were implemented in a hospital
network. In addition to timely staff education and promotion of directly observed hand hygiene, reverse-transcription polymerase chain
reaction for norovirus was performed as an added test by the microbiology laboratory for all fecal specimens irrespective of the request
for testing. Laboratory-confirmed cases were followed up by the infection control team for timely intervention. The incidence of hospital-
acquired norovirus infection per 1,000 potentially infectious patient-days was compared with the corresponding period in the preceding
12 months, and the incidence in the other 6 hospital networks in Hong Kong was chosen as the concurrent control. Phylogenetic analysis
of norovirus isolates was performed.
results. Of the 988 patients who were tested, 242 (25%) were positive for norovirus; 114 (47%) of those 242 patients had norovirus
detected by our added test. Compared with the corresponding period in the preceding 12 months, the incidence of hospital-acquired
norovirus infection decreased from 131 to 16 cases per 1,000 potentially infectious patient-days ( ), although the number of hospital-P ! .001
acquired infections was low in both the study period ( ) and the historical control periods ( ). The incidence of hospital-acquirednp 8 np 11
norovirus infection in our hospital network (0.03 cases per 1,000 patient-days) was significantly lower than that of the concurrent control
(0.06 cases per 1,000 patient-days) ( ). Forty-three (93%) of 46 norovirus isolates sequenced belonged to the genogroup II.4 variant.Pp .015
conclusions. Strategic infection control measures with an added test may be useful in controlling nosocomial transmission of norovirus.
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Norovirus is a nonenveloped, single-stranded RNA virus be-
longing to the family of Caliciviridae, which is a causative
agent for acute gastroenteritis, often referred to as “winter
vomiting disease.” Norovirus can cause major outbreaks in
both communities and hospitals, with a high clinical attack
rate due to its low infectious dose of 10–100 particles, relative
resistance to disinfecting agents, and environmental survival
of up to 2 days.1 With the emergence of a specific genogroup
II.4 variant since 2002, there has been a dramatic increase in
the number of reported outbreaks all over the world,2 in-
cluding in Hong Kong.3 In the summer of 2006, there were
36 nosocomial outbreaks of norovirus in 19 of 41 public
hospitals in Hong Kong affecting 218 patients, most of them
elderly.4 Control of nosocomial outbreaks of norovirus in-
fection often requires infection control measures that include
closure of a ward, contact isolation precaution, and extensive
environmental disinfection.5,6 These measures disrupt patient
care and increase both the workload of frontline staff and
the costs to healthcare institutions.7
During the pandemic outbreak of infection with the novel
influenza A H1N1 virus, we successfully demonstrated the
effectiveness of enhanced infection control measures in pre-
venting nosocomial transmission of this novel virus.8 Here,
we further tested strategic infection control measures target-
ing norovirus during the winter, when the average temper-
ature was 16C (range, 14C–20C) and the relative humidity
was around 70%.9 By incorporating an “added test” for no-
rovirus in the microbiology laboratory, the sequence of in-
fection control actions by the infection control team pre-
vented any nosocomial outbreaks of norovirus infection in
our hospital while the number of outbreaks of norovirus
infection in the other public hospitals in Hong Kong re-
mained unchanged this year.
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methods
Infection Control Measures for Norovirus
In collaboration with the stakeholders, including hospital ad-
ministrators, clinicians, and nursing colleagues, strategic in-
fection control measures were established to prevent noso-
comial transmission of norovirus infection. Open staff forums
and special education sessions were arranged by the hospital
administration and infection control team. Fecal specimens
were collected for all hospitalized patients who had diarrheal
symptoms on admission or during hospitalization. Reverse-
transcription polymerase chain reaction (RT-PCR) for the
ORF1 gene of norovirus was performed upon request by the
attending clinician (the “ordered test”). However, RT-PCR
for norovirus was also performed as an added test by the
microbiology laboratory for all fecal specimens that were re-
quested for bacterial culture, Clostridium difficile culture, or
cytotoxin, and rotavirus antigen detection without a request
for norovirus detection. The infection control team checked
with the microbiology laboratory on a daily basis for any test
results positive for norovirus.
Cases were assessed at the bedside to confirm that patients
had symptomatic diarrhea when fecal specimens were col-
lected and to determine the route of acquisition. Community-
acquired infection was defined as present if a patient had
diarrheal symptoms upon or within 48 hours after admission
and had no history of contact with any confirmed case in
the hospital. Hospital-acquired infection was defined as pres-
ent if a patient had onset of diarrhea after 48 hours of
hospitalization.
The source of nosocomial transmission of norovirus was
investigated by the infection control team with the aim to
identify areas for improvement. The infection control team
also advised healthcare workers on isolation and contact pre-
cautions for all laboratory-confirmed cases. An infection con-
trol action cascade was introduced in our hospital. Briefly,
infection control nurses made daily, unannounced visits to
areas at high risk for outbreaks of norovirus infection to
detect any lapse in infection control practice. An infection
control nurse contacted the high-risk areas by phone during
public holidays and weekends to ensure that appropriate pa-
tient placement was made for all patients with nosocomial
onset of diarrhea. A high-risk area was defined as any clinical
unit or ward in which nosocomial transmission of diarrheal
pathogens had been reported in the past 12 months.10 A nos-
ocomial outbreak was defined as 3 or more laboratory-
confirmed cases of hospital-acquired norovirus infection in
the same ward. When nosocomial outbreaks of norovirus
infection occurred in the other hospitals in Hong Kong, our
infection control team would immediately review relevant
patient care practices and hospital environments to lower the
corresponding risk factors, if present, that may contribute to
a nosocomial outbreak.
Hand hygiene using an alcohol-based hand rub (World
Health Organization formulation) was promoted in 2006 and
fully implemented in our hospital in 2007. Directly observed
hand hygiene practice was promoted, especially in the high-
risk areas as previously described.11 Compliance with hand
hygiene practices has been regularly audited by the infection
control team according to a predetermined protocol.12 The
consumption data of alcohol-based hand rub retrieved from
the pharmacy was calculated in terms of liters per 1,000
patient-days.
Epidemiology of Norovirus in Queen Mary Hospital
This study was performed in Queen Mary Hospital, a 1,400-
bed tertiary referral university-affiliated hospital with 3 adult
isolation wards and 1 pediatric isolation ward, under the
governance of hospital network A in Hong Kong. Except for
general pediatric patients who were routinely admitted into
isolation facilities when they presented with diarrheal illness,
all other patients, including surgical pediatric patients, were
placed in the nonisolation facilities upon admission in view
of the limitation of isolation facilities. Hospitalized patients
were transferred to 4 chronic care hospitals designated for
rehabilitation and extended medical care with a total of 1,200
beds within hospital network A when their acute conditions
stabilized. Hospital network A is estimated to provide clinical
service to a population of approximately 0.53 million. Our
microbiology laboratory provides service to 5 hospitals in
hospital network A. From November 1, 2009, to February
28, 2010, all fecal specimens sent to the microbiology labo-
ratory were subjected to norovirus RT-PCR as either an or-
dered test or an added test, with a turnaround time of 1 day.
The overall positive rate of norovirus infection in hospital
network A was described. The epidemiology and nosocomial
transmission of norovirus infection diagnosed in Queen Mary
Hospital was analyzed. The number of potentially infectious
patient-days for norovirus was defined as the interval from
onset of diarrhea upon admission or during hospitalization
to the implementation of infection control practice, including
cohort nursing or single room isolation. The number of hos-
pital-acquired norovirus infections in the corresponding pe-
riod (November–February) in the preceding 12 months was
retrieved for comparison to assess the effectiveness of our
infection control measures.
Nosocomial Outbreak of Norovirus Infection in
Hong Kong
In Hong Kong, there are 7 hospital networks comprising 41
public hospitals under the management of the Hospital Au-
thority, which serves over 90% of the 7 million people in
Hong Kong. The infection control officer of a hospital is
responsible for monitoring the occurrence of nosocomial out-
breaks and reporting to the Hospital Authority if the outbreak
might have a public health impact. The number of exposed
patients and staff in each outbreak of norovirus infection was
retrieved from the Hospital Authority. The number and clin-
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figure 1. Weekly number of RT-PCR for norovirus and results of hospital patients in Queen Mary Hospital (from November 1, 2009,
to February 28, 2010). An “added test” is defined as the test performed by the microbiology laboratory on all fecal specimens that were
sent only for bacterial culture, Clostridium difficile culture or cytotoxin test, and rotavirus antigen detection without a request for norovirus
investigation; an “ordered test” is defined as the test requested by the attending clinician. Wk 44, week 44 of 2009, represents November
1–7, 2009; Wk 44 of 2009 to Wk 7 of 2010 is defined as a 7-day interval; Wk 8, week 8 of 2010, represents February 21–28, 2010.
ical attack rates of the nosocomial outbreaks in all 7 hospital
networks in the corresponding period of 2009 were reported.
The incidence of hospital-acquired norovirus infection in the
hospital network was expressed in 1,000 patient-days.
Molecular Diagnosis and Phylogenetic Analysis of
Norovirus by Real-Time RT-PCR
A 10% (wt/vol) fecal suspension was prepared with viral
transport medium and clarified by centrifugation at 3,000 g
for 20 minutes. Total nucleic acid was extracted from 250 mL
of the 10% clarified fecal suspension with NucleiSens
easyMAG instrument (bioMerieux, Boxtel, Netherlands) ac-
cording to the manufacturer’s instructions. Extracted RNA
was reverse-transcribed to complementary DNA (cDNA) us-
ing the SuperScript II kit (Invitrogen, San Diego, CA) with
random primer as previously described.13 Real-time RT-PCR
for norovirus was performed by using primers to amplify the
ORF1-ORF2 junction region and probes for genotype 1 and
II as previously described with modification.14 PCR ampli-
fication was performed with a LightCycler 2.0 (Roche Di-
agnostic) under the following conditions: initial denaturation
at 95C for 10 minutes (preamplification hot start), and then
50 cycles of amplification with denaturation at 95C for 10
seconds, annealing at 56C for 15 seconds, and extension at
72C for 12 seconds. Amplification data were collected and
analyzed with LightCycler 4.1 software (Roche Diagnostic).
Published sequences of representative norovirus strains
from GenBank were included for alignments and phyloge-
netic analysis. The accession numbers are New Orleans 1905/
2009/USA (GU445325), NSW001P/2008/AU (GQ845367),
DOUG4770/GII.4 (AF406793), Burwash Landing/331/1995/
USA (AF414425), FUMI/2010/JP (AB543808), Hu/GII/281/
2006/HKG (EF121839), Hu/GII/733/2006/HKG (EF121840),
Lordsdale/1993/UK (X86557), Camberwell/1994/AU
(HCU46500), Miami/292/1994/US (AF414410), Gwynedd/
273/1994/US (AF414409), Toronto/24/1999/CA (U02030),
Mexico/1989/MX/ (U22498), Lionville/247/1993/US
(AF414411), Richmond/283/1994/US (AF414419),
White_river (AF414423), Melksham/1989/UK (X81879), Hu/
GII/NoV750/2004/CA (EF078288), Saitama T80GII/02/JP
(AB112293), Saitama U25 (AB039780), Hu/GII.4/Nijme-
gen115/2006 (EF126966), Hu/GII.4/DenHaag89/2006
(EF126965), Cairo2/2006 (EU876882), Cairo4/2006
(EU876884), Ichikawa/2005 (AB294787), Sakai/04-179/2005
(AB220922), Kashiwa/060802/2006 (AB2947789), Kashiwa/
060802/2006 (EF126964), Aomori1/2006 (AB447432), Al-
melo039/2004 (AB303938), Hu/GII.4/2004 (AY883096),
Apeldoorn023/2003 (AB303931), Kaiso/030556/2003
(AB294779/2001), Houston/TCH186/2002 (EU310927),
Stockholm/19865/2008 (AB492092), Apeldoorn317/2007
(AB445395), Dijon/E3743/2009 (GQ246798), Dijon/E4032/
2009 (GQ246801).
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figure 2. Laboratory-confirmed cases of norovirus infection per 1,000 patient-days in Queen Mary Hospital (from November 1, 2009,
to February 28, 2010). Wk 44, week 44 of 2009, represents November 1–7, 2009; Wk 44 of 2009 to Wk 7 of 2010 is defined as a 7-day
interval; Wk 8, week 8 of 2010, represents February 21–28, 2010.
Genotyping PCR and Sequencing
The norovirus genotyping I and II were performed using the
primary and secondary seminested PCR assays and conditions
described previously.14,15 All positive PCR products from ei-
ther primary or secondary seminested PCR assays were pu-
rified with a QIAquick PCR purification kit (Qiagen, Hilden,
Germany) and were sequenced in both directions with BigDye
Teminator Cycle Sequencing Ready Reaction kit version 3.1
(Applied Biosystems, California, USA) with corresponding
specific primers and an ABI 3130 Genetic Analyzer (Applied
Biosystems, New Jersey, USA).
Statistical Analysis
The Fisher exact test was used to compare independent cat-
egorical variables between groups. A P value of less than .05
was considered statistically significant. Computation was per-
formed using EpiInfo 3.5.1 (CDC).
results
Infection Control Measures for Norovirus
Between November 1, 2009, and February 28, 2010, there
were 9 sessions of a staff forum held in hospital network A,
with an overall attendance of 1,031 (26%) of 3,925 healthcare
workers, to update medical knowledge and infection control
practice to prevent nosocomial transmission of norovirus.
Including the basic and special infection control training ses-
sions held previously, a total of 3,594 professional staff mem-
bers (91.6%) have attended our infection control training in
the past 18 months.
A previous audit of hand hygiene practice showed a gradual
increase in compliance in all clinical departments from 25%
to 59% of opportunities between 2006 and 2008. When a
yearly audit was performed in November 2009, the overall
rate of hand hygiene compliance of hospital staff was con-
sistently between 60% and 70%. The consumption of alcohol-
based hand rub increased from 1.5 L per 1,000 patient-days
in 2006, 18.8 L per 1,000 patient-days in 2007, and 25.3 L
per 1,000 patient-days in 2008 to 26.9 L per 1,000 patient-
days in 2009.
Epidemiology of Norovirus in Queen Mary Hospital
During the study period, 1,612 fecal specimens from 1,153
hospitalized patients from hospital network A were received
for microbiology investigation, of which 1,416 fecal specimens
from 988 patients were collected in Queen Mary Hospital.
Of the 1,416 fecal specimens collected from 659 patients, 957
(68%) were classified as “added test.” Two hundred forty-
two (25%) of 988 patients tested positive for norovirus by
RT-PCR; 114 (47%) of those 242 patients had norovirus de-
tected by our added test. Among these 114 patients, 1 patient
was coinfected with Aeromonas caviae, 1 patient with toxi-
genic C. difficile, 4 patients with nontoxigenic C. difficile, and
1 pediatric patient with rotavirus. The weekly number of
ordered tests and added tests for norovirus and the percentage
of tests with a positive result are illustrated in Figure 1.
Among the 242 patients with laboratory-confirmed no-
rovirus infection, there were 142 females and 100 males, with
a median age of 57 years (range, 1 month to 101 years).
Seventy-four (31%) of 242 patients were aged 3 years or
younger while 106 (44%) of them were aged 70 years or older.
Fifty-two (21%) patients were long-term-care home residents.
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table 2. Nosocomial Outbreak of Norovirus Infection in the Public Hospitals in Hong Kong during Winter 2009–2010
Outbreak
number
Hospital,
network Clinical unit Date of outbreak
Duration of
outbreak,
days
No. of infected
patients/no. of
exposed patients
Clinical
attack
rate
among
patients, %
No. of infected
staff/no. of
exposed staff
Clinical
attack
rate
among
staff, %
1 A, B Rehabilitation Oct 29–Nov 12, 2009 15 7/42 17 1/30 3
2 B, C Pediatric Nov 14–27, 2009 14 4/22 18 4/49 8
3 C, D Rehabilitation Nov 19–Dec 3, 2009 14 10/24 42 3/30 10
4 D, E Neurosurgery Nov 30–Dec 11, 2009 12 6/29 21 8/36 22
5 E, F Orthopedic Dec 3–14, 2009 12 10/36 28 0/41 0
6 F, B Rehabilitation Dec 4–15, 2009 12 9/52 17 1/28 4
7 G, F Psychiatry Dec 20–31, 2009 12 12/31 39 0/31 0
8 H, D General medicine Dec 21–24, 2009 4 10/46 21 0/58 0
9 I, G General medicine Dec 26, 2009–Jan 2,
2010
8 6/40 15 0/40 0
10 J, G Tuberculosis and
chest
Jan 5–15, 2010 11 8/31 26 3/31 10
11 E, F Rehabilitation Jan 9–20, 2010 12 13/39 33 1/31 3
12 H, D Integrated ward Jan 12–18, 2010 7 3/16 19 0/45 0
13 E, F Rehabilitation Jan 18–Feb 4, 2010 18 15/36 42 0/28 0
Total 113/444 25 21/478 4
Patients were admitted into general medical wards (111
[46%]), pediatric wards (76 [31%]), surgical wards (21 [9%]),
emergency admission wards (21 [9%]), high dependence unit
(7 [3%]), orthopedic wards (3 [1%]), and obstetric wards (3
[1%]). The epidemic of norovirus peaked during week 47 of
2009, when the incidence density reached 5.25 cases per 1,000
patient-days with 78 potentially infectious patient-days (Fig-
ure 2). Our infection control nurses assessed all 242 patients
with norovirus infection admitted to 37 different wards at
the bedside and confirmed that all patients were having symp-
tomatic diarrhea when fecal specimens were collected for ex-
amination. Seventy-four patients had been cared for in iso-
lation facilities upon clinical assessment, while 168 patients
were managed in general wards, accounting for 496 poten-
tially infectious patient-days with a mean duration of 3.1 
1.1 days. Most of the patients (234 [96.7%]) had community-
acquired infection; 8 (3.3%) had hospital-acquired infection
(Table 1). Five (63%) of 8 patients had infection diagnosed
by the added test. Eight episodes of hospital-acquired infec-
tion in 496 potentially infectious patient-days were docu-
mented. Using the data from the corresponding period (No-
vember–February) of the preceding 12 months as historical
control, there were 11 episodes of hospital-acquired infection
among 24 nonisolated patients in 84 potentially infectious
patient-days (mean number of potentially infectious patient-
days, 3.8  3.7 days). The incidence of hospital-acquired
infection decreased from 131 to 16 cases per 1,000 potentially
infectious patient-days ( ). Assuming that added testsP ! .001
were not provided to hospital network A patients during this
period, there were only 3 hospital-acquired norovirus infec-
tions with 173 potentially infectious patient-days. Even then,
the incidence of hospital-acquired infection (15 cases per
1,000 potentially infectious patient-days) was still significantly
lower than that of the historical control period (131 cases
per 1,000 potentially infectious patient-days) ( ). NoP ! .001
nosocomial outbreak was reported during the study period.
Nosocomial Outbreak of Norovirus in Hong Kong
If we exclude hospital network A, where the strategic infection
control measures against norovirus infection prevented any
nosocomial outbreak of norovirus infection, there were 13
episodes of nosocomial outbreak of norovirus infection re-
ported in the other 6 hospital networks (B–G) in the winter
of year 2009, which could be served as a concurrent control
(Table 2). Ten (24%) out of 41 public hospitals in Hong Kong
were affected, involving acute medical, surgical, pediatric, or-
thopedic, psychiatric, and chronic rehabilitation units. In hos-
pital E, 3 repeated outbreaks were observed. A total of 113
patients and 21 hospital staff members were infected, with
the clinical attack rates ranging from 15% to 42% and from
3% to 22%, respectively. No visitors were involved. The me-
dian duration of the nosocomial outbreak was 12 days (4–
18 days). Nine (69%) of 13 nosocomial outbreaks were re-
ported in November and December 2009. The overall inci-
dence of hospital-acquired norovirus infection was 0.06 cases
per 1,000 patient-days among 6 hospital networks (B–G),
which was significantly higher than that of hospital network
A (0.03 cases per 1,000 patient-days) ( ).Pp .015
Molecular Diagnosis and Phylogenetic Analysis of
Norovirus
Forty-six (19%) out of 242 strains of norovirus isolated dur-
ing the study period were selected for sequencing (Figure
figure 3. Phylogenetic dendrogram of norovirus. A, Phylogenetic dendrogram generated based on the ORF 1/2 junction region of norovirus
using novel sequences in isolates from this study ( ) and GenBank ( ); Norowalk/1968/US was used as the outgroup. B, Anp 46 np 20
further subtree generated from the genotype group II.4 variants ( ) and GenBank ( ). Numbers on the branches representnp 43 np 20
bootstrap values after 1,000 replications, and bootstrap values ≥50 are shown. An asterisk represents the strains collected from patients
with hospital-acquired infection. A number sign represents the 470491 strain collected from index patients as a source of nosocomial
patient-to-patient transmission.
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3A). Except for 3 patients with community-acquired noro-
virus due to genogroup II.2, genogroup II.3, all other patients’
isolates belonged to genogroup II.4 variant, of which 4 isolates
were closed to genogroup II.4 variant 2006b and 39 isolates,
including 6 isolates from patients with nosocomial onset of
diarrhea, were closed to the 2008 variant16 (Figure 3B).
discussion
Norovirus has caused numerous outbreaks, affecting about
25% of all public hospitals in Hong Kong during the winter
months of 2009, involving all clinical disciplines from acute
to long-term patient care areas. With the implementation of
strategic infection control measures in Queen Mary Hospital
and its 4 network hospitals in 2009, we were able to prevent
any nosocomial outbreak of norovirus infection and reduce
the incidence of hospital-acquired norovirus infection from
131 to 16 cases per 1,000 potentially infectious patient-days.
The concept of using an added test for early recognition of
any index case was simple but innovative. Without affecting
the clinical workflow of the frontline medical and nursing
staff, all fecal specimens referred to the microbiology labo-
ratory were tested for norovirus RT-PCR, regardless of the
clinician’s request. The provision of rapid laboratory diag-
nostic testing facilitated timely intervention by our infection
control team, who provided advice as to patient placement,
isolation precautions, and thorough environmental disinfec-
tion with sodium hypochlorite (1,000 ppm), thus preventing
an outbreak.
The overall compliance with standard infection control
practice was satisfactory among our frontline healthcare
workers, especially after the intensive training in infection
control during the emergence of pandemic influenza in mid-
2009 in Hong Kong.9 The rate of compliance with hand hy-
giene practice approached 70% in November 2009 among all
ranks of healthcare workers, and the consumption of alcohol-
based hand rub solution increased even before our imple-
mentation of enhanced infection control measures. In this
connection, none of the healthcare workers reported diarrhea
after caring for the infected patients upon contact tracing. In
addition, directly observed hand hygiene (DOHH) practice,
which has proved effective in outbreak prevention and con-
trol,17,18 was further enforced by our infection control nurses
when there was any evidence of nosocomial acquisition of
norovirus. This might be useful in preventing outbreaks
evolving from episodic cases. However, the use of alcohol-
based hand rub has been questioned in the control and pre-
vention of norovirus, a nonenveloped RNA virus, especially
if the concentration of ethanol is less than 80% and the con-
tact time is less than 20 seconds.19,20 Although the WHO
formulation of alcohol-based hand rub, formula I containing
ethanol (80% vol/vol), has been used in our center, further
investigation is needed to examine the effectiveness of al-
cohol-based hand rub against norovirus infection.
Molecular sequencing of norovirus isolated during the win-
ter of 2009 demonstrated a predominant strain of genotype
II.4 variant. This epidemic strain has emerged in the United
States and European countries since 2002 and arrived in Hong
Kong in 2006, resulting in an increased number of nosocomial
outbreaks.2,4,21 It is the first demonstration that nosocomial
transmission of this epidemic strain of norovirus can be pre-
vented by the implementation of strategic infection control
measures.
Cost-effective analysis based on previous studies in Hong
Kong showed that the minimum cost of each nosocomial
outbreak of norovirus in Hong Kong is around HK$311,580
(US$40,000).4 The minimum cost of 13 reported nosocomial
outbreaks in Hong Kong is HK$4,050,540 (US$520,000).
Since the extra cost for the strategic infection control mea-
sures is the added test for rapid molecular diagnostic of no-
rovirus, HK$200 (US$25) per test, the minimum cost for
added tests during the winter in Hong Kong is HK$1,400,000
(US$180,000) (approximately 1,000 added tests per hospital
network times 7 networks in Hong Kong times HK$200).
Performing these added tests would result in a potential sav-
ings of around HK$2,600,000 (US$340,000).
There are several limitations in this study. First, the number
of hospital-acquired norovirus infections in our cohort was
low, and therefore the risk factors for nosocomial transmis-
sion of norovirus cannot be investigated from a statistical
perspective. However, the risk factors of nosocomial acqui-
sition of norovirus have been well reported; lapses in infection
control practice in nonisolation facilities and introduction of
infection by a contaminated food source or symptomatic
healthcare workers were found to be important risk fac-
tors.22-27 In fact, all of our hospital-acquired norovirus infec-
tions occurred because of one of the reasons mentioned
above. Second, the incidence of hospital-acquired norovirus
infection in the study and historical control periods should
be carefully interpreted because of the difference in case find-
ing which might potentially introduce bias in the concurrent
comparison of hospital-acquired norovirus infection between
different hospital networks. The total number of nosocomial
norovirus outbreaks in Hong Kong during the study period
might be underestimated because private hospitals are not
required to notify the Hospital Authority of an outbreak.
However, the impact is probably trivial because the public
hospital system serves more than 90% of Hong Kong’s pop-
ulation. Frequent reports of norovirus outbreaks in public
hospitals involving a wide range of clinical specialties indi-
cated that the promotion of our strategic infection control
measures is justified to decrease nosocomial transmission of
norovirus.
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